U.S. natural gas prices upside likely in 2026 - Morgan Stanley
SS&C Technologies Holdings Inc. (NASDAQ:SSNC) has reached an all-time high, with its stock price soaring to $89.25. This milestone reflects a significant period of growth for the company, as evidenced by the impressive 1-year change data showing a 38.1% increase. Investors have shown increased confidence in SS&C’s market position and its ability to sustain growth, propelling the stock to new heights. The company’s performance is a testament to its strategic initiatives and the robust demand for its financial services and software solutions. As SS&C continues to innovate and expand its offerings, market watchers remain attentive to how the stock will perform in the coming months.
In other recent news, SS&C Technologies Holdings, Inc. reported strong fourth-quarter earnings, with total revenue and adjusted EBITDA surpassing DA Davidson’s estimates by 3% and 1%, respectively. The company also provided initial guidance for 2025, forecasting year-over-year growth in adjusted revenue between 3.4% and 6.1%, and adjusted earnings per share (EPS) expected to increase by 4% to 10%. Analysts at UBS, DA Davidson, Needham, and Jefferies have all shown confidence in SS&C’s future, with UBS and Needham setting a price target of $105, DA Davidson at $102, and Jefferies at $94, each maintaining a Buy rating. Additionally, SS&C Technologies has expanded its capabilities through the acquisition of FPS Trust Company, enhancing its benefit payment solutions for institutional clients.
The acquisition of FPS Trust is expected to strengthen SS&C’s managed services and optimize custodial offerings. Analysts have highlighted SS&C’s strategic investments and organic growth as key factors in its industry-leading position. Jefferies upgraded SS&C from Hold to Buy, citing the company’s potential to sustain mid-single-digit organic growth and return to 40% adjusted EBITDA margins. The company’s focus on capital deployment and new customer acquisitions, particularly through investments in DomaniRx, is seen as a positive indicator of future growth. These developments underscore SS&C’s commitment to enhancing client relationships and achieving operational efficiency.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.